Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk

Dow Jones

2025/09/25

0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. "Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth," Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

September 24, 2025 22:02 ET (02:02 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2570707053"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2570707053\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2570707053?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-25 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2570707053","market":"fut","top_or_hot":-1,"title":"Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 24, 2025 22:02 ET (02:02 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ebos Gets Bull as Earnings Base Nears Reset -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEbos Gets Bull as Earnings Base Nears Reset -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-09-25 10:02</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 24, 2025 22:02 ET (02:02 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EBO.AU","symbol_name":"EBOS GROUP LIMITED","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2570707053","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2570707053","pubTimestamp":1758765720,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EBO.AU":"EBOS GROUP LIMITED","EBO.NZ":"Ebos Group Limited Ordinary Shares","BK8046":"保健护理产品经销商","BK7103":"保健护理产品经销商"},"translate_title":"随着盈利基础接近重置，Ebos看涨——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBO.AU":0.9,"EBO.NZ":0.9},"content_text":"0202 GMT - Pharmacy group Ebos gets a new bull in Forsyth Barr, which sees FY 2026 as a year when its earnings base is reset. Analyst Matt Montgomerie says it is heartening that Ebos's FY 2026 guidance implies a sequential stabilization in Ebitda margins from a weak 2H of FY 2025. \"Beyond FY 2026, we believe the combination of improved facility utilization, boosted pharmacy wholesaler funding, gradual retendering of pharmacy contracts, and financial leverage should provide robust EPS growth,\" Forsyth Barr says. It forecasts EPS rising at a compound annual rate of 10% in FY 2025-FY 2029. Forsyth Barr upgrades Ebos to outperform from neutral. Ebos is down 1% at NZ$28.89. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 24, 2025 22:02 ET (02:02 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}